Skip to main content
. 2024 Jun 27;12(8):e00199-24. doi: 10.1128/spectrum.00199-24

TABLE 1.

Antibiotics resistance profiles of RGM clinical strains in this studya

Strains Species SXT LZD CIP IMI MXF FOX AMI DOX MIN TOB CLA
MAB1 M. abscessus R R R I R R S R R R R
MAB4 M. abscessus R R R R R I S R R R I
MAB5 M. abscessus R R R I R R S R R R R
MC4 M. chelonae S R S R S R S I S R R
MC6 M. chelonae R S S I S R S R R S S
MC7 M. chelonae R I R R R R S R R S S
MF1 M. fortuitum R S S I S R R R R R R
MF3 M. fortuitum R R R I S I S R R R R
MF6 M. fortuitum R R S R S R S R R R R
a

Determined using broth microdilution-based automated antimicrobial susceptibility testing (AST) system SENSITITRE RAPMYCOI (TREK/Thermo Scientific). S: Susceptible; I: Intermediate; R: Resistant. Antibiotics: SXT, trimethoprim/sulfamethoxazole; LZD, linezolid; CIP, ciprofloxacin; IMI, imipenem; MXF, moxifloxacin; FOX, cefoxitin; AMI, amikacin; DOX, doxycycline; MIN, minocycline; TOB, tobramycin; CLA, clarithromycin.